MedPath
FDA Approval

carboprost tromethamine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 23, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Carboprost tromethamine(250 ug in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals of New York, LLC

860156658

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

carboprost tromethamine

Product Details

NDC Product Code
70121-1680
Application Number
ANDA215337
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
December 23, 2023
Code: U4526F86FJClass: ACTIMQuantity: 250 ug in 1 mL
TROMETHAMINEInactive
Code: 023C2WHX2VClass: IACTQuantity: 83 ug in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 9.45 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath